FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 50 filers reported holding FORTRESS BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | -99.9% | 13,221 | -38.1% | 0.00% | -50.0% |
| Q3 2022 | $18,000 | +63.6% | 21,359 | +57.5% | 0.00% | +100.0% |
| Q2 2022 | $11,000 | -86.7% | 13,560 | -47.3% | 0.00% | -85.7% |
| Q3 2021 | $83,000 | -21.7% | 25,714 | -22.9% | 0.01% | -36.4% |
| Q4 2020 | $106,000 | -54.7% | 33,333 | -42.4% | 0.01% | -72.5% |
| Q3 2020 | $234,000 | +377.6% | 57,872 | +90.7% | 0.04% | +1233.3% |
| Q3 2018 | $49,000 | -30.0% | 30,348 | +98.2% | 0.00% | -25.0% |
| Q1 2018 | $70,000 | +1.4% | 15,311 | -2.2% | 0.00% | +33.3% |
| Q3 2017 | $69,000 | – | 15,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |